Patent · US Expired

Family of anti-carcinoembryonic antigen chimeric antibodies

US5472693A · kind A · utility

43Cited by
5References
10Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 16, 1993
Grant dateDec 5, 1995
Priority date
Expiry dateFeb 16, 2013

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/24
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention discloses novel chimeric monoclonal antibodies directed against human carcinoembryonic antigen, having antigen-specific variable regions. DNA constructs for the light and heavy chain variable regions comprising the novel antibodies of the invention are also disclosed. Eukaryotic host cells capable of expression of the chimeric antibodies and comprising the novel chimeric antibody-encoding DNA constructs are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.